Advanced Tumor Marker Testing
PSA, CA125 & CA19.9 | Expert Cancer Screening in Dubai

رزرو نوبت
نظرات تأیید شده بیماران مرکز تشخیصی DCDC در دبی
نظرات تأیید شده و داستانهای واقعی بیماران از شهر سلامت دبی
از این کلینیک پزشکی بسیار راضی هستم. اولین غربالگری بارداری خود را اینجا انجام دادم. قیمت مناسب و بسیار حرفهای بود. رادیولوژیست خوشامدگو، مهربان بود و تجربه عالیای داشتم.
آیژان توکمانبتووا
جمعه شب زانویم آسیب دید و یکشنبه عصر وقت MRI گرفتم (یکشنبه بعدازظهر رزرو کردم). حدود ۲ دقیقه صبر کردم و در کمتر از ۳۰ دقیقه کارم تمام شد. تیم فوقالعاده، دوستانه و کارآمد بود.
کریستن اوانز
تیم دکتر اسامه مهربان و فوقالعاده بود. بعد از یک تجربه بد در جای دیگر، معاینه لگن من اینجا بسیار حرفهایتر بود. گزارش عالی و بسیار دقیق.
ماری



Tumor Markers Blood Test in Dubai: PSA, CA125 & CA19.9 Screening
Early detection through accurate cancer marker analysis at DHCC

Focused Panel
PSA, CA125, and CA19.9 — the most validated cancer screening markers
Early Detection
Identify potential malignancies before symptoms develop
Fast Results
Most tumor marker results available within 24-48 hours
Specialist Pathway
Direct referral to oncology, gynaecology, or urology if needed
Cancer remains one of the leading causes of morbidity and mortality in the United Arab Emirates, with prostate, ovarian, and gastrointestinal malignancies accounting for a significant proportion of diagnoses. According to the UAE National Cancer Registry, cancer incidence has risen steadily over the past decade, driven by population growth, changing lifestyles, and increased diagnostic awareness. Tumor marker blood tests play a vital role in the early detection and monitoring of these cancers, offering a non-invasive first step that can prompt timely specialist referral and potentially life-saving intervention.
Tumor markers are substances, usually proteins, produced by cancer cells or by the body in response to cancer. While no single tumor marker provides a definitive cancer diagnosis on its own, these biomarkers are invaluable tools when combined with clinical history, imaging, and physical examination. At DCDC in Dubai Healthcare City, we offer a focused panel of the most clinically validated tumor markers: Total PSA for prostate cancer screening, CA125 for ovarian cancer assessment, and CA19.9 for pancreatic and gastrointestinal cancer evaluation. Each marker serves a distinct clinical purpose and is interpreted within the context of the individual patient.

Focused Panel
PSA, CA125, and CA19.9 — the most validated cancer screening markers
Early Detection
Identify potential malignancies before symptoms develop
Fast Results
Most tumor marker results available within 24-48 hours
Specialist Pathway
Direct referral to oncology, gynaecology, or urology if needed
Tumor Markers Blood Test in Dubai: PSA, CA125 & CA19.9 Screening
Early detection through accurate cancer marker analysis at DHCC
Cancer remains one of the leading causes of morbidity and mortality in the United Arab Emirates, with prostate, ovarian, and gastrointestinal malignancies accounting for a significant proportion of diagnoses. According to the UAE National Cancer Registry, cancer incidence has risen steadily over the past decade, driven by population growth, changing lifestyles, and increased diagnostic awareness. Tumor marker blood tests play a vital role in the early detection and monitoring of these cancers, offering a non-invasive first step that can prompt timely specialist referral and potentially life-saving intervention.
Tumor markers are substances, usually proteins, produced by cancer cells or by the body in response to cancer. While no single tumor marker provides a definitive cancer diagnosis on its own, these biomarkers are invaluable tools when combined with clinical history, imaging, and physical examination. At DCDC in Dubai Healthcare City, we offer a focused panel of the most clinically validated tumor markers: Total PSA for prostate cancer screening, CA125 for ovarian cancer assessment, and CA19.9 for pancreatic and gastrointestinal cancer evaluation. Each marker serves a distinct clinical purpose and is interpreted within the context of the individual patient.

Dr. Hadi Komshi
خدمات Tumor Markers ما
خدمات جامع tumor markers در DCDC شهر سلامت دبی.
تمام خدمات توسط متخصصان دارای مجوز DHA انجام میشود
چه کسانی باید Tumor Markers انجام دهند؟
Tumor marker testing is recommended for individuals with risk factors for cancer, those with symptoms that may suggest malignancy, and patients undergoing cancer treatment monitoring. Your physician may order these tests based on clinical findings, family history, or screening guidelines.
Men over 50, or over 40 with family history of prostate cancer, for PSA screening
Women with pelvic masses, bloating, or family history of ovarian cancer for CA125
Patients with unexplained abdominal pain, weight loss, or jaundice for CA19.9
Individuals with a first-degree relative diagnosed with prostate, ovarian, or pancreatic cancer
Patients with known cancer undergoing treatment for response monitoring
Post-treatment cancer survivors for recurrence surveillance
Why Choose DCDC for Tumor Marker Testing?
MOHAP-licensed laboratory with advanced immunoassay technology, rapid turnaround, and integrated specialist referral pathways for comprehensive cancer screening.
MOHAP Licensed
Accredited diagnostic laboratory with certified tumor marker testing protocols and quality assurance.
Rapid Results
Most tumor marker results ready within 24-48 hours for timely clinical decision-making.
Insurance Support
Direct billing with 20+ insurers. Tumor markers typically covered with physician referral.
Convenient Location
Building 64, Block A in Dubai Healthcare City. Walk-ins welcome with appointment preferred.
Advanced Immunoassay
State-of-the-art analyzers calibrated to international reference standards for reliable results.
Specialist Integration
On-site internists, gynaecologists, and urologists for immediate follow-up of abnormal findings.
مراجعه راحت شما
فرآیند اسکن Tumor ساده و گام به گام که برای راحتی، سرعت و دقت طراحی شده است.
Tumor Marker Testing Pricing
قیمت Tumor در دبی بسته به نوع خدمت و پوشش بیمه برای انواع مختلف خدمات متفاوت است.
- قیمتها بسته به نوع اسکن و نیاز به ماده حاجب متفاوت است
- پوشش بیمه با ارجاع و تأیید پذیرفته میشود
- نرخهای شفاف پرداخت نقدی با قیمتگذاری فوری در صورت درخواست
تأیید بیمه در چند دقیقه • بدون هزینه پنهان • پاسخ سریع در واتساپ
راهنمای بیمار
What to Expect During Tumor Marker Testing
A simple blood draw with minimal preparation and fast turnaround.
بیمه و موقعیت
شرکای بیمه
- •بیش از ۲۰ شرکت بیمه در دبی از جمله ضمان، آکسا، ادنیک و دیگران
- •پشتیبانی پیشتأیید و صورتحساب مستقیم (در صورت امکان)
- •بررسی پوشش بیمه قبل از نوبت شما در کلینیک ما در شهر بهداشت دبی
- •قیمتگذاری شفاف بدون هزینه پنهان برای خدمات tumor markers
به ما در شهر سلامت دبی سر بزنید
مرکز تشخیصی کلینیک پزشکان
ساختمان ۶۴، بلوک A، مجتمع پزشکی الرازی، شهر سلامت دبی، دبی، امارات متحده عربی
نزدیک جاده عود متحا · دسترسی آسان از بر دبی، داونتاون دبی، بیزینس بی · پارکینگ اختصاصی رایگان موجود
ساعات کاری
شنبه-پنجشنبه: ۸ صبح - ۱۰ شب | جمعه: ۹ صبح - ۹ شب
نحوه عملکرد بیمه در DCDC
بررسی پوشش
بررسی کنید که بیمه شما Tumor Markers را پوشش میدهد
دریافت ارجاع
برخی بیمهها نیاز به ارجاع پزشک عمومی دارند — ما راهنمایی میکنیم
پیشتأیید
ما پیشتأیید را مستقیماً با بیمهگر انجام میدهیم
فاکتور مستقیم
بدون پرداخت اولیه — ما مستقیماً با بیمهگر تسویه میکنیم
فقط سهم بیمار
فقط سهم بیمار قابل اعمال را در کلینیک پرداخت میکنید
بررسی پوشش
بررسی کنید که بیمه شما Tumor Markers را پوشش میدهد
دریافت ارجاع
برخی بیمهها نیاز به ارجاع پزشک عمومی دارند — ما راهنمایی میکنیم
پیشتأیید
ما پیشتأیید را مستقیماً با بیمهگر انجام میدهیم
فاکتور مستقیم
بدون پرداخت اولیه — ما مستقیماً با بیمهگر تسویه میکنیم
فقط سهم بیمار
فقط سهم بیمار قابل اعمال را در کلینیک پرداخت میکنید
متخصص شما

Dr. Hadi Komshi
Specialist Internal Medicine
MD, Specialist Internal Medicine
فارسی · عربی · انگلیسی
Conditions and Cancers Assessed Through Tumor Markers
Prostate Cancer
PSA is the primary screening and monitoring marker for prostate cancer, the most common non-skin cancer in men.
Ovarian Cancer
CA125 is used to evaluate suspected ovarian masses, monitor treatment response in diagnosed ovarian cancer, and surveil high-risk women with BRCA mutations or strong family history.
Pancreatic Cancer
CA19.9 supports the diagnosis and monitoring of pancreatic adenocarcinoma, with elevated levels correlating with tumor burden and helping predict surgical resectability.
Colorectal Cancer
CA19.9 may be elevated in colorectal malignancies and is sometimes used alongside CEA for monitoring treatment response and detecting recurrence.
خدمات مرتبط
سایر خدمات تشخیصی و مشاورهای موجود در کلینیک ما در شهر سلامت دبی را کاوش کنید.
سؤالات متداول
سؤالات متداول درباره Tumor Markers در دبی.
Tumor markers are proteins produced by cancer cells or the body in response to cancer, measured through a blood test. They serve four functions: screening at-risk individuals, supporting diagnosis, monitoring treatment effectiveness, and detecting recurrence.
PSA (Prostate Specific Antigen) is produced by normal and cancerous prostate cells. Below 4.0 ng/mL is generally normal; 4.0-10.0 is a grey zone where approximately 25 percent may have cancer; above 10.0 carries higher probability.
CA125 is a protein elevated in ovarian cancer (80 percent of advanced cases) but also in endometriosis, fibroids, PID, and menstruation. It is most useful for evaluating women with persistent bloating, pelvic pain, or difficulty eating, and for monitoring diagnosed ovarian cancer.
CA19.9 is a protein shed by pancreatic and GI cancer cells. Below 37 U/mL is generally normal; above 100 U/mL is associated with pancreatic cancer.
Yes. PSA is elevated by BPH, prostatitis, and cycling.
اطلاعات کلیدی
نظارت پزشکی
تمام خدمات تحت نظارت متخصصین پزشکی دارای مجوز در مرکز معتبر وزارت بهداشت ارائه میشود.












